This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Treatment with eribulin mesilate could suppress epithelial– mesenchymal transition (EMT) in tumors of patients with metastatic breast cancer – preliminary report of a prospective study. (February 2017)
Record Type:
Journal Article
Title:
Treatment with eribulin mesilate could suppress epithelial– mesenchymal transition (EMT) in tumors of patients with metastatic breast cancer – preliminary report of a prospective study. (February 2017)
Main Title:
Treatment with eribulin mesilate could suppress epithelial– mesenchymal transition (EMT) in tumors of patients with metastatic breast cancer – preliminary report of a prospective study